Latros International

Bloemfontein 9301

0 studies enrolling now · 2 studies all time

What they study most

Diabetic Nephropathies, Severe Hypertriglyceridemia

Studies at this site

• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed